Janney Montgomery Scott’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-38,451
Closed -$6.01M 2424
2020
Q4
$6.01M Sell
38,451
-6,655
-15% -$1.04M 0.03% 483
2020
Q3
$5.16M Buy
45,106
+1,277
+3% +$146K 0.03% 475
2020
Q2
$4.92M Sell
43,829
-392
-0.9% -$44K 0.03% 460
2020
Q1
$3.97M Buy
44,221
+10,637
+32% +$955K 0.03% 457
2019
Q4
$3.63M Sell
33,584
-545
-2% -$58.9K 0.02% 572
2019
Q3
$3.34M Buy
34,129
+11,408
+50% +$1.12M 0.02% 569
2019
Q2
$2.98M Buy
22,721
+2,627
+13% +$344K 0.02% 584
2019
Q1
$2.72M Buy
20,094
+1,339
+7% +$181K 0.02% 594
2018
Q4
$1.83M Buy
18,755
+1,707
+10% +$166K 0.02% 673
2018
Q3
$2.37M Sell
17,048
-173
-1% -$24.1K 0.02% 645
2018
Q2
$2.14M Sell
17,221
-265
-2% -$32.9K 0.02% 658
2018
Q1
$1.95M Buy
17,486
+4,069
+30% +$454K 0.02% 661
2017
Q4
$1.61M Buy
13,417
+34
+0.3% +$4.07K 0.02% 738
2017
Q3
$1.88M Sell
13,383
-158
-1% -$22.2K 0.02% 641
2017
Q2
$1.65M Buy
13,541
+5,186
+62% +$631K 0.02% 647
2017
Q1
$1.01M Buy
8,355
+671
+9% +$81.4K 0.01% 832
2016
Q4
$940K Sell
7,684
-834
-10% -$102K 0.01% 796
2016
Q3
$1.04M Buy
+8,518
New +$1.04M 0.02% 642
2016
Q2
Sell
-6,790
Closed -$945K 1241
2016
Q1
$945K Sell
6,790
-537
-7% -$74.7K 0.02% 536
2015
Q4
$1.4M Sell
7,327
-242
-3% -$46.2K 0.04% 443
2015
Q3
$1.18M Buy
7,569
+1,211
+19% +$189K 0.03% 475
2015
Q2
$1.15M Buy
6,358
+1,322
+26% +$239K 0.02% 713
2015
Q1
$873K Buy
5,036
+618
+14% +$107K 0.02% 972
2014
Q4
$817K Buy
4,418
+333
+8% +$61.6K 0.02% 970
2014
Q3
$677K Buy
4,085
+250
+7% +$41.5K 0.01% 1067
2014
Q2
$599K Sell
3,835
-1,482
-28% -$232K 0.01% 1110
2014
Q1
$809K Buy
5,317
+513
+11% +$78K 0.02% 844
2013
Q4
$638K Sell
4,804
-312
-6% -$41.5K 0.02% 933
2013
Q3
$594K Buy
+5,116
New +$594K 0.02% 900